Literature DB >> 17900567

Conditioned place aversion organized in the dorsal periaqueductal gray recruits the laterodorsal nucleus of the thalamus and the basolateral amygdala.

Janaina M Zanoveli1, Cristina Ferreira-Netto, Marcus L Brandão.   

Abstract

The amygdala-ventral periaqueductal gray circuit is crucial for the expression of contextual conditioned fear. However, little is known about the neural circuits activated when the stimulation of the dorsal periaqueductal gray (dPAG) is used as unconditioned stimulus (US) in conditioned fear paradigms. The present paper examines the Fos-protein distribution in the brain of rats submitted to a conditioned place aversion (CPA) paradigm using the dPAG chemical stimulation with semicarbazide (SMC), an inhibitor of the GABA synthesizing enzyme, as US and the quadrant of an arena where the drug was injected as the paired neutral stimulus. Our results show that CPA associated with SMC injections caused a significant Fos labeling in the laterodorsal nucleus of the thalamus (LD), basolateral nucleus of amygdala (BLA) and in the dorsomedial PAG (dmPAG). This pattern of brain activation is clearly different from the neural substrates of the classical fear conditioning reported in the literature. Moreover, this paper shows that CPA with the use of chemical stimulation of the dPAG could be used as an experimental model of panic disorder with agoraphobia in the extent that panic attacks repeatedly associated with specific contexts may turn in this condition in the clinics. This condition activates the BLA probably through the LD. Besides, it indicates that the dPAG can be the link between amygdala and the brainstem motor regions that controls CPA when dPAG stimulation is used as US instead of footshocks. From this evidence we suggest that a loop dPAG-LD-BLA-dPAG is activated during the panic disorder with agoraphobia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17900567     DOI: 10.1016/j.expneurol.2007.08.007

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  10 in total

1.  Periaqueductal gray c-Fos expression varies relative to the method of conditioned taste aversion extinction employed.

Authors:  G Andrew Mickley; Gina N Wilson; Jennifer L Remus; Linnet Ramos; Kyle D Ketchesin; Orion R Biesan; Joseph R Luchsinger; Suzanna Prodan
Journal:  Brain Res       Date:  2011-09-22       Impact factor: 3.252

Review 2.  Contextual conditioning in rats as an animal model for generalized anxiety disorder.

Authors:  Laura Luyten; Debora Vansteenwegen; Kris van Kuyck; Loes Gabriëls; Bart Nuttin
Journal:  Cogn Affect Behav Neurosci       Date:  2011-06       Impact factor: 3.282

3.  A similar pattern of neuronal Fos activation in 10 brain regions following exposure to reward- or aversion-associated contextual cues in mice.

Authors:  Zachary V Johnson; Andrew A Revis; Mallory A Burdick; Justin S Rhodes
Journal:  Physiol Behav       Date:  2009-12-21

4.  Chronic ketamine impairs fear conditioning and produces long-lasting reductions in auditory evoked potentials.

Authors:  Laura C Amann; Tobias B Halene; Richard S Ehrlichman; Stephen N Luminais; Nan Ma; Ted Abel; Steven J Siegel
Journal:  Neurobiol Dis       Date:  2009-05-23       Impact factor: 5.996

5.  Stimulation of the dorsal periaqueductal gray enhances spontaneous recovery of a conditioned taste aversion.

Authors:  G Andrew Mickley; Kyle D Ketchesin; Linnet Ramos; Joseph R Luchsinger; Morgan M Rogers; Nathanael R Wiles; Nita Hoxha
Journal:  Brain Res       Date:  2012-11-23       Impact factor: 3.252

Review 6.  Common brain activations for painful and non-painful aversive stimuli.

Authors:  Dave J Hayes; Georg Northoff
Journal:  BMC Neurosci       Date:  2012-06-07       Impact factor: 3.288

7.  Identifying a network of brain regions involved in aversion-related processing: a cross-species translational investigation.

Authors:  Dave J Hayes; Georg Northoff
Journal:  Front Integr Neurosci       Date:  2011-10-03

8.  Antianxiety medications for the treatment of complex agoraphobia: pharmacological interventions for a behavioral condition.

Authors:  Giampaolo Perna; Silvia Daccò; Roberta Menotti; Daniela Caldirola
Journal:  Neuropsychiatr Dis Treat       Date:  2011-10-19       Impact factor: 2.570

9.  Scopolamine Induces Deficits in Spontaneous Object-Location Recognition and Fear-Learning in Marmoset Monkeys.

Authors:  Jonathan L Melamed; Fernando M de Jesus; Rafael S Maior; Marilia Barros
Journal:  Front Pharmacol       Date:  2017-06-21       Impact factor: 5.810

10.  Electrical stimulation of the bed nucleus of the stria terminalis reduces anxiety in a rat model.

Authors:  K Luyck; T Tambuyzer; M Deprez; J Rangarajan; B Nuttin; L Luyten
Journal:  Transl Psychiatry       Date:  2017-02-14       Impact factor: 6.222

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.